Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma

Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma

Abstract. Background:. Circulating tumor DNA (ctDNA) is a promising biomarker for non-invasive epidermal growth factor receptor mutations (EGFRm) detection in lung cancer patients, but existing methods have limitations in sensitivity and availability. In this study, we used the ΔCt value (mutant cyc...

Full description

Bibliographic Details
Main Authors: Xiang-Liang Liu, Ri-Lan Bai, Xiao Chen, Yu-Guang Zhao, Xu Wang, Ke-Wei Ma, Hui-Min Tian, Fu-Jun Han, Zi-Ling Liu, Lei Yang, Wei Li, Fei Gai, Jiu-Wei Cui, Pei-Fang Wei
Format: Article
Language:English
Published: Wolters Kluwer 2021-10-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000001760

Internet

http://journals.lww.com/10.1097/CM9.0000000000001760

Similar Items